This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Uroxatral 10 mg tablets, a medication used to treat benign prostatic hyperplasia. The contract has a ceiling value of $17,717.97 and a completion date of September 14, 2023. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,363.70, is for the delivery of Uroxatral 10 mg tablets, a medication used to treat benign prostatic hyperplasia. This is a Firm Fixed Price Delivery Order contract with a completion date of December 1, 2022. The contract does not have a set-aside designation, indicating open competition....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Uroxatral 10 mg tablets. The $11,916.73 award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which provides a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has no set-aside...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of Uroxatral 10 mg tablets. The award has a ceiling value of $9,596.91 and a performance period through April 2, 2024. The contract is a firm fixed price delivery order, and no set-aside designation was used. AmerisourceBergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) awarded by DLA, with a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The order is for 4,565,545,429 units of Uroxatral 10 mg tablets, with a firm fixed price of $4,145.56 and an ultimate completion date of August 23, 2024. This order is not set aside for any special designation. As a key supplier of medical commodities to federal agencies, Amerisourcebergen holds multiple Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 100 tablets of Uroxatral 10 mg, a medication used to treat enlarged prostate. The fixed-price contract has a ceiling value of $10,098.36 and a performance period ending on June 29, 2023. The contract was not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
The U.S. Department of Defense's Medical Supply Chain has awarded a $53,367.30 firm fixed-price delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of 4,558,845,821 units of the prescription medication Uroxatral 10 mg tablets in 100-count packages. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4559576181 - UROXATRAL 10 MG TABLET 100S. The firm-fixed-price contract has a ceiling value of $2,599.00 and a completion date of January 12, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $20,208.61 firm fixed-price contract is for the delivery of UROXATRAL 10 MG TABLET 100S, a medication used to treat symptoms of an enlarged prostate. The contract has an ultimate completion date of August 17, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA valued at...
This is a $50,847.34 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Uroxatral 10 mg tablets, a medication used to treat the symptoms of an enlarged prostate. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which provides a comprehensive range of pharmaceutical...